Drug Pricing Reform Gathers Steam (Part 1): White House Drug Pricing Plan Offers Laundry List of Existing Democrat Priorities
FDA Law Blog
SEPTEMBER 13, 2021
Medicare negotiation authority; encourage biosimilars and generic drug utilization). One proposal is a cap on out-of-pocket costs, primarily to help beneficiaries with expensive chronic conditions that can face large, even catastrophic, out-of-pocket spending every year. Part D currently has no such cap. ADMINISTRATIVE ACTIONS.
98 
Let's personalize your content